Format

Send to

Choose Destination
See comment in PubMed Commons below
Zhongguo Zhen Jiu. 2012 Mar;32(3):224-6.

[Observation on therapeutic effect of migraine treated with medicated threads moxibustion of Zhuang nationality].

[Article in Chinese]

Author information

1
Clinical Teaching and Research Department, College of Traditional Zhuang Medicine, Guangxi University of CM, Nanning 530001, China. 1007965808@qq.com

Abstract

OBJECTIVE:

To observe the therapeutic effect and adverse reaction of migraine treated with medicated threads moxibustion of Zhuang nationality.

METHODS:

One hundred and twenty cases of migraine were randomly divided into a medicated threads group and a medication group. Sixty cases were treated with medicated threads moxibustion of Zhuang nationality in medicated threads group, and 60 cases were treated by Ergotamine and Caffeine tablets with oral administration in medication group. All the cases in both groups were continuously treated for 30 days. The score changes of headache and the adverse reactions of patients were observed, and the therapeutic effects were evaluated.

RESULTS:

The scores of headache after treatment were lower than those before treatment in both groups, indicating the statistically significant differences (both P < 0.05); compared with the scores of headache between both groups after treatment, there was no significant difference (P > 0.05). The total effective rate in medicated threads group was 93.3% (56/60) and 90.0% (54/60) in medication group, and there was no significant difference in comparison of therapeutic effects of both groups (P > 0.05). There was no any adverse reaction in medicated threads group; the symptoms such as flushing and discomfort of upper abdomen, etc. appeared in 20 cases in medication group.

CONCLUSION:

The therapeutic effect of migraine treated with medicated threads moxibustion of Zhuang nationality is significantly effective, and there is no any adverse reaction.

PMID:
22471135
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center